As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Latest articles from Genome Medicine
Read the latest papers on Cancer across BMC flagship journals.
Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study
Lei Huang et al.
Published in BMC Medicine 25 March 2019
An RNAi screen of Rho signalling networks identifies RhoH as a regulator of Rac1 in prostate cancer cell migration
Virginia Tajadura-Ortega et al.
Published in BMC Biology 06 March 2018
Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis
Markus Mayrhofer et al.
Published in Genome Medicine 21 November 2018
Dynamic inosinome profiles reveal novel patient stratification and gender-specific differences in glioblastoma
Domenico Alessandro Silvestris et al.
Published in Genome Biology 13 February 2019